Texas State Optical Silsbee Optometrist Medicare: Not Enrolled in Medicare Practice Location: 125 N 5th St, Silsbee, TX 77656 Phone: 409-385-5262 Fax: 409-385-6497 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 127 N 5th St, Silsbee, TX 77656 Phone: 409-385-5262 Fax: 409-385-6497 |
Doctors Eye Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 710 Highway 327 E, Silsbee, TX 77656 Phone: 409-385-2811 Fax: 409-385-6696 |
Dr. Brian Ratcliff, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1205 Highway 327 E, Silsbee, TX 77656 Phone: 409-385-2811 |
Azka Ahmed, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 127 N 5th St, Silsbee, TX 77656 Phone: 409-385-5262 Fax: 409-385-6497 |
Mr. Edward Vorster, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1205 Highway 327 E, Silsbee, TX 77656 Phone: 409-385-2811 Fax: 409-385-6696 |
News Archive
The Associated Press: A new study says about 2 million of the 12 million cancer survivors in the United States put off medical care because they cannot afford it. "The study is being called the first to estimate how often current and former patients have skipped getting care because of money worries. It was led by Kathryn Weaver, a researcher at Wake Forest University Baptist Medical Center in Winston-Salem, N.C.
A study from Hospital for Special Surgery (HSS) finds that in morbidly obese patients, bariatric surgery performed prior to a total hip or knee replacement can reduce in-hospital and 90-day postoperative complications and improve patient health, but it does not reduce the risk of needing a revision surgery.
In 2010, the US National Comprehensive Cancer Network guidelines suggested that patients with stable and low-risk prostate cancers could be managed with active surveillance or watchful waiting (AS/WW). AS/WW was considered to be a safe and effective alternative to aggressive surgery to remove the prostate and radiation therapy.
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.
› Verified 6 days ago